Found: 18
Select item for more details and to access through your institution.
Fibrates and the risk of cardiovascular outcomes in chronic kidney disease patients.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 6, p. 1016, doi. 10.1093/ndt/gfad248
- By:
- Publication type:
- Article
Epigenetic clocks indicate that kidney transplantation and not dialysis mitigate the effects of renal ageing.
- Published in:
- Journal of Internal Medicine, 2024, v. 295, n. 1, p. 79, doi. 10.1111/joim.13724
- By:
- Publication type:
- Article
Risk factors for blood vessel rupture during vascular access intervention therapy for hemodialysis patients.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0283844
- By:
- Publication type:
- Article
Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality.
- Published in:
- Journal of Bone & Mineral Metabolism, 2021, v. 39, n. 2, p. 260, doi. 10.1007/s00774-020-01144-8
- By:
- Publication type:
- Article
Incidence of Fractures Before and After Dialysis Initiation.
- Published in:
- Journal of Bone & Mineral Research, 2020, v. 35, n. 12, p. 2372, doi. 10.1002/jbmr.4141
- By:
- Publication type:
- Article
Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 11, p. 1908, doi. 10.1093/ndt/gfz142
- By:
- Publication type:
- Article
Bone mineral density and mortality in end-stage renal disease patients.
- Published in:
- Clinical Kidney Journal, 2020, v. 13, n. 3, p. 307, doi. 10.1093/ckj/sfaa089
- By:
- Publication type:
- Article
Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto Rats.
- Published in:
- Kidney & Blood Pressure Research, 2020, v. 45, n. 3, p. 391, doi. 10.1159/000506286
- By:
- Publication type:
- Article
Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224690
- By:
- Publication type:
- Article
FC020 BONE MINERAL DENSITY AT VARIOUS SITES VERSUS MORTALITY IN END-STAGE RENAL DISEASE (ESRD).
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, p. N.PAG, doi. 10.1093/ndt/gfz096.FC020
- By:
- Publication type:
- Article
Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial.
- Published in:
- Journal of Bone & Mineral Research, 2019, v. 34, n. 6, p. 1014, doi. 10.1002/jbmr.3676
- By:
- Publication type:
- Article
Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar–Kyoto rats through anti-inflammatory effects.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 5, p. 774, doi. 10.1093/ndt/gfy201
- By:
- Publication type:
- Article
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0206865
- By:
- Publication type:
- Article
Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.
- Published in:
- Nephrology Dialysis Transplantation, 2018, v. 33, n. 4, p. 598, doi. 10.1093/ndt/gfx264
- By:
- Publication type:
- Article
The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193846
- By:
- Publication type:
- Article
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0158154
- By:
- Publication type:
- Article
Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism.
- Published in:
- Tohoku Journal of Experimental Medicine, 2016, v. 238, n. 3, p. 205, doi. 10.1620/tjem.238.205
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0111728
- By:
- Publication type:
- Article